Tag Archives: Sangamo Biosciences

Wedbush Keeps a Hold Rating on Sangamo Biosciences (SGMO)

Wedbush analyst Liana Moussatos reiterated a Hold rating on Sangamo Biosciences (NASDAQ: SGMO) today and set a price target of $10. The company’s shares opened today at $14.80. According to TipRanks.com, Moussatos is a 3-star analyst with an average return

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sangamo Biosciences (NASDAQ: SGMO) and Neurocrine (NASDAQ: NBIX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sangamo Biosciences (NASDAQ:SGMO) and Neurocrine (NASDAQ:NBIX). Sangamo Biosciences (SGMO) In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Sangamo Biosciences,

Sangamo Biosciences Receives a New Rating from Cowen & Co.

Sangamo Biosciences (NASDAQ: SGMO) received a Buy rating from Cowen & Co. analyst Ritu Baral today. The company’s shares opened today at $15.45. According to TipRanks.com, Baral is a top 100 analyst with an average return of 37.6% and a

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sangamo Biosciences (NASDAQ: SGMO) and VBI Vaccines (NASDAQ: VBIV)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sangamo Biosciences (NASDAQ: SGMO) and VBI Vaccines (NASDAQ: VBIV). Sangamo Biosciences (NASDAQ: SGMO) Wedbush analyst Liana Moussatos reiterated a Hold rating on Sangamo Biosciences (NASDAQ:

Barclays Believes Sangamo Biosciences (NASDAQ: SGMO) Still Has Room to Grow

Barclays analyst Gena Wang maintained a Buy rating on Sangamo Biosciences (NASDAQ: SGMO) on February 22 and set a price target of $30. The company’s shares closed on Friday at $24.95, close to its 52-week high of $27.50. According to

Wedbush Keeps a Hold Rating on Sangamo Biosciences

Wedbush analyst Liana Moussatos reiterated a Hold rating on Sangamo Biosciences (NASDAQ: SGMO) today and set a price target of $6. The company’s shares opened today at $14.65. According to TipRanks.com, Moussatos is a 4-star analyst with an average return